Notably, our LASSO model demonstrated excellent diagnostic performance (AUC > 0.7) across multiple cohorts, indicating its potential superiority over traditional serological markers (RF or ACPA) in identifying RA. The gene discussed is PRTN3; the disease is rheumatoid arthritis.